Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2026: Door to Unload Randomized Clinical Trial
Author(s): Babar Basir , Karim Al-Azizi Added: 2 weeks ago
ACC 2026 — Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, front-line interventional view of the STEMI Door-to-Unload (STEMI-DTU) trial (NCT03000270), making this an efficient 5-minute update for cardiologists and cath lab teams.STEMI-DTU randomised haemodynamically stable patients aged 18–85 years with a first acute… View more

Intervention

MI/ACS
Author(s): Mohaned Egred , Juan Luis Gutiérrez-Chico , Carlo Tumscitz , et al Added: 3 weeks ago
Welcome to our exclusive video series featuring leading interventional cardiologists sharing their real-world experiences with Excimer Laser Coronary Atherectomy (ELCA). Through clinical insights, case discussions and practical tips, these videos reveal how ELCA plays a critical role in tackling today's most challenging lesions – from in-stent restenosis to undilatable, uncrossable lesions and… View more

Intervention
ILUMIEN-V-AERO: Study Design
Author(s): Nitin Chandramohan , Mamas A Mamas , Mohammed Balgith , et al Added: 3 months ago

Intervention

MI/ACS
The Hybrid Approach in CAD with Restore® DEB
Author(s): Alfonso Ielasi Added: 1 year ago
In this comprehensive video series, Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, IT) delves into the approach of using Restore® Drug-Eluting Balloon (DEB) in treating Coronary Artery Disease (CAD). View more

Intervention
Ultimaster TANSEI in Complex Coronary Lesions
Author(s): Ricardo Palma-Carbajal , Yassin Belahnech , José M de la Torre Hernández , et al Added: 1 week ago

Intervention

MI/ACS
The FISH&CHIPS Study: Real-world Study Reveals Significant Reduction in All-cause and Cardiovascular Mortality
Author(s): Jonathon A Leipsic Added: 2 years ago
FISH&CHIPS two-year key outcomes associated with availability of FFRCT include:A significant 14% relative reduction in cardiovascular mortality and a significant 8% relative reduction in all-cause mortality.An increase in cath lab efficiency, driven by a 5% relative reduction in invasive cardiac angiography (ICA) and an 8% relative increase in Percutaneous Coronary Intervention (PCI).A 14%… View more

Guidelines & Statements

Imaging & Diagnostics
NY Valves 25: Early Clinical and QoL Outcomes of the PASCAL System
Author(s): Santiago Garcia Added: 9 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings… View more

Intervention
TR Aetiology & Clinical Outcomes with Prof Denisa Muraru
Author(s): Denisa Muraru Added: 3 months ago
Discover why tricuspid regurgitation aetiology matters for patient outcomes and intervention strategies with Prof Denisa MuraruThis presentation, part of a comprehensive series on complex cases in interventional cardiology, explores how understanding TR mechanisms directly impacts diagnosis, treatment selection, and clinical prognosis.Prof Muraru addresses the critical heterogeneity in TR… View more

Intervention
NY Valves 25: The Tri-QOL Study
Author(s): Added: 9 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result… View more

Intervention
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 10 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention